Nationwide Registry-Based Analysis of Infective Endocarditis Risk After Pulmonary Valve Replacement.

ABSTRACT: Background Infective endocarditis (IE) after pulmonary valve replacements in congenital heart disease is a significant concern. This study aimed to identify specific long-term risk factors for IE after percutaneous pulmonary valve implantation or surgical pulmonary valve replacement. Methods and Results All patients with congenital heart disease from the National Register for Congenital Heart Defects with at least 1 pulmonary valve replacement before January 2018 were included. A total of 1170 patients (56.3% men, median age at study inclusion 12 [interquartile range {Q1-Q3} 5-20 years]) received 1598 pulmonary valve replacements. IE occurred in 4.8% of patients during a follow-up of total 9397 patient-years (median 10 [Q1-Q3, 6-10] years per patient). After homograft implantation 7 of 558

SUBMITTER: Stammnitz C 

PROVIDER: S-EPMC9075093 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature